english.prescrire.org > Topics > Advancing healthcare policy > EMEA transparency policy falls short: a weak and irresponsible project (9/2009)
Advancing healthcare policy

Via its policy advocacy, Prescrire acts as a force for change in health policies, first and foremost in the interest of patients.

Français

EMEA transparency policy falls short: a weak and irresponsible project Joint Answer to EMEA Consultation, (September 2009)

In their anwer to European Medicines Agency (EMEA)'s public consultation, Prescrire and its allies find EMEA's draft transparency policy to be weak and irresponsible. They call for EMEA's full accountability to the public. Real transparency is an indispensable prerequisite to restore EU citizens’ confidence in EMEA’s decisions. Read on...
 

In their anwer to European Medicines Agency (EMEA)'s public consultation, Prescrire and its allies find EMEA's draft transparency policy to be weak and irresponsible. They call for EMEA's full accountability to the public. Real transparency is an indispensable prerequisite to restore EU citizens’ confidence in EMEA’s decisions.

© September 2009

> Click here for the full document "EMEA transparency policy falls short: a weak and irresponsible project", a joint answer by HAI Europe, ISDB and MiEF to "The EMEA transparency policy – draft for public consultation" (pdf, 382 Ko).